Suppr超能文献

图像引导的低分割放疗与局限性前列腺癌的生活质量:337 例患者的前瞻性纵向研究。

Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.

机构信息

Department of Radiation Oncology, European Institute of Oncology, Milan, Italy.

出版信息

J Urol. 2013 Jun;189(6):2099-103. doi: 10.1016/j.juro.2013.01.005. Epub 2013 Jan 9.

Abstract

PURPOSE

We prospectively analyzed quality of life in a cohort of patients with prostate cancer undergoing a course of hypofractionated image guided radiotherapy.

MATERIALS AND METHODS

Between August 2006 and January 2011, 337 patients with a median age of 73 years who had cT1-T2N0M0 prostate cancer were eligible for this prospective, longitudinal study of hypofractionated image guided radiotherapy (70.2 Gy/26 fractions) using 1 of 3 image guided radiotherapy modalities (transabdominal ultrasound, x-ray or cone beam computerized tomography) available in our radiation oncology department. Patients completed 4 questionnaires before treatment, and 6, 12 and 24 months later, including the International Index of Erectile Function-5, International Prostate Symptom Score, and EORTC (European Organization for Research and Treatment of Cancer) prostate cancer specific QLQ-PR25 and QLQ-C30.

RESULTS

Patient followup was updated to at least the last questionnaire time point. Median followup was 19 months. Significant deterioration in erectile function on the International Index of Erectile Function-5 was documented with time only in patients without androgen deprivation (p = 0.0002). No change with time was observed in urinary symptom related quality of life on the QLQ-PR25 or International Prostate Symptom Score. Slight deterioration in QLQ-PR25 bowel symptom related quality of life was observed (p = 0.02). Overall QLQ-C30 Global Health Status improved with time (p = 0.03). On univariate analysis it significantly correlated with the maximum RTOG (Radiation Therapy Oncology Group)/EORTC urinary and bowel late toxicity scores after radiotherapy.

CONCLUSIONS

The regimen of hypofractionated image guided radiotherapy with multiple imaging modalities adopted in our radiation oncology department for localized prostate cancer might be a successful strategy for dose escalation with a limited impact on different aspects of quality of life with time.

摘要

目的

我们前瞻性地分析了接受分次图像引导放疗的前列腺癌患者队列的生活质量。

材料与方法

2006 年 8 月至 2011 年 1 月期间,337 名中位年龄为 73 岁的 cT1-T2N0M0 前列腺癌患者符合这项前瞻性、纵向研究的条件,这些患者接受了 1 种在我们放射肿瘤科可用的 3 种图像引导放疗方式(经腹超声、X 射线或锥形束计算机断层扫描)中的 1 种进行的分次图像引导放疗(70.2Gy/26 次)。患者在治疗前、治疗后 6、12 和 24 个月时完成了 4 份问卷,包括国际勃起功能指数-5、国际前列腺症状评分以及 EORTC(欧洲癌症研究与治疗组织)前列腺癌特异性 QLQ-PR25 和 QLQ-C30。

结果

患者随访更新至最后一次问卷时间点。中位随访时间为 19 个月。仅在未接受雄激素剥夺治疗的患者中,国际勃起功能指数-5 上的勃起功能随着时间显著恶化(p = 0.0002)。在 QLQ-PR25 或国际前列腺症状评分上,尿症状相关生活质量没有随时间而改变。QLQ-PR25 肠道症状相关生活质量稍有恶化(p = 0.02)。总体 QLQ-C30 全球健康状况随时间改善(p = 0.03)。在单变量分析中,它与放疗后最大 RTOG(放射治疗肿瘤学组)/EORTC 尿和肠道迟发性毒性评分显著相关。

结论

我们放射肿瘤科采用的分次图像引导放疗方案和多种成像方式治疗局限性前列腺癌可能是一种成功的剂量递增策略,对不同方面的生活质量的影响有限。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验